Associations between decreases in adiposity and reductions in HbA1c and insulin use in the Look AHEAD cohort
Authors:
- Kristen M. BeaversKBKristen M. Beavers
- Denise K. HoustonDHDenise K. Houston
- Karen C. JohnsonKJKaren C. Johnson
- Mark A. EspelandMEMark A. Espeland
- For the Action for Health in Diabetes (Look AHEAD) Aging Study GroupFGFor the Action for Health in Diabetes (Look AHEAD) Aging Study Group
Open Access
Abstract
Objective: The objective of this study was to elucidate associations between adiposity reduction and changes in HbA1c and insulin use among adults with type 2 diabetes and overweight or obesity.Methods: Changes in BMI, waist circumference, and total percent fat mass were obtained over 8 years among 1316 individuals (aged 45–76 years) enrolled in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss. Generalized linear models were used to assess relationships between 5% decreases in adiposity measures with glycated hemoglobin (HbA1c) and insulin use over time.Results: A 5% reduction in total percent fat was associated with 0.15% (95% CI: 0.12%–0.18%) lower mean HbA1c. Similarly, 5% reductions in waist circumference and BMI were also associated with slightly lower mean HbA1c: 0.16% (95% CI: 0.13%–0.19%) and 0.13% (95% CI: 0.11%–0.16%), respectively. These reductions were associated with lower odds of insulin use over time, ranging from 21% lower odds for a 5% reduction in percent body fat to 32% lower odds for 5% reductions in waist circumference and BMI. Associations were evident across subgroups defined by sex, diabetes duration, obesity status, and intervention assignment.Conclusions: Reductions in adiposity are associated with stabilized and slightly lower HbA1c and a marked reduction in the need for insulin therapy. These benefits generalize across clinical subgroups.Keywords
Funding Information
- National Institute on Aging (U01AG073697)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK57136, DK57149, DK56990, DK57177, DK57171, DK571)
This publication has 32 references indexed in Scilit:
- 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension studyThe Lancet Diabetes & Endocrinology, 2024
- Why does obesity cause diabetes?Cell Metabolism, 2022
- Does Lifestyle Intervention Improve Health of Adults with Overweight/Obesity and Type 2 Diabetes? Findings from the Look AHEAD Randomized TrialObesity, 2021
- Sex differences in metabolic regulation and diabetes susceptibilityDiabetologia, 2019
- Changes in regional body composition over 8 years in a randomized lifestyle trial: The look AHEAD studyObesity, 2016
- Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: The look AHEAD studyObesity, 2015
- Eight‐year weight losses with an intensive lifestyle intervention: The look AHEAD studyObesity, 2013
- Association of an Intensive Lifestyle Intervention With Remission of Type 2 DiabetesJAMA, 2012
- Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes MellitusArchives of internal medicine (1960), 2010
- Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetesControlled Clinical Trials, 2003